Current strategies to detect, manage and control carbapenemase-producing Enterobacteriaceae in NHS acute hospital trusts in the UK: time for a rethink?
作者信息
Winzor G, Hussain A
机构信息
Public Health Laboratory Birmingham, Public Health England, UK; Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, UK; Birmingham Heartlands Hospital, Birmingham, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Public Health Laboratory Birmingham, Public Health England, UK; Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, UK; Birmingham Heartlands Hospital, Birmingham, UK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
出版信息
J Hosp Infect. 2018 Sep;100(1):13-14. doi: 10.1016/j.jhin.2018.04.018. Epub 2018 Apr 23.
Abstract
摘要
相似文献
1
Current strategies to detect, manage and control carbapenemase-producing Enterobacteriaceae in NHS acute hospital trusts in the UK: time for a rethink?英国国民保健服务体系（NHS）急性医院信托机构中检测、管理和控制产碳青霉烯酶肠杆菌科细菌的当前策略：是否需要重新思考？
J Hosp Infect. 2018 Sep;100(1):13-14. doi: 10.1016/j.jhin.2018.04.018. Epub 2018 Apr 23.
2
Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).英国尿标本中产碳青霉烯酶肠杆菌科细菌的耐药率和产酶情况：英国感染-碳青霉烯类耐药评估监测试验（iCREST-UK）的结果。
J Antimicrob Chemother. 2018 Mar 1;73(3):698-702. doi: 10.1093/jac/dkx471.
3
An evaluation of a toolkit for the early detection, management, and control of carbapenemase-producing Enterobacteriaceae: a survey of acute hospital trusts in England.产碳青霉烯酶肠杆菌科的早期检测、管理和控制工具包的评估：对英格兰急性医院信托的调查。
J Hosp Infect. 2018 Aug;99(4):381-389. doi: 10.1016/j.jhin.2018.03.007. Epub 2018 Mar 9.
4
[Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review].[急性环境中碳青霉烯酶产生肠杆菌科细菌暴发的控制：证据综述]
Rev Chilena Infectol. 2017 Aug;34(4):421. doi: 10.4067/s0716-10182017000400421.
5
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.碳青霉烯类药物暴露前史是产非碳青霉烯酶类碳青霉烯耐药肠杆菌科和产碳青霉烯酶肠杆菌科的危险因素。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00845-19. Print 2019 Oct.
6
Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.英国产碳青霉烯酶肠杆菌科细菌：一项关于患病率、发病率、实验室检测方法和感染控制措施的全国性研究（英国欧洲疾病预防控制中心抗菌药物耐药性监测项目）
J Antimicrob Chemother. 2017 Feb;72(2):596-603. doi: 10.1093/jac/dkw414. Epub 2016 Sep 29.
7
Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?加州耐碳青霉烯肠杆菌科检测实践：我们遗漏了什么？
Clin Infect Dis. 2018 Mar 19;66(7):1061-1067. doi: 10.1093/cid/cix942.
8
Development and evaluation of the method for detecting metallo-carbapenemases among carbapenemase-producing Enterobacteriaceae.开发和评估检测产金属碳青霉烯酶肠杆菌科的方法。
J Microbiol Methods. 2019 Aug;163:105652. doi: 10.1016/j.mimet.2019.105652. Epub 2019 Jun 13.
9
Notes from the Field: Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera - United States, 2014-2017.实地记录：2014 - 2017年美国从罕见肠杆菌科属中分离出的产碳青霉烯酶耐碳青霉烯类肠杆菌科细菌
MMWR Morb Mortal Wkly Rep. 2018 Jun 15;67(23):668-669. doi: 10.15585/mmwr.mm6723a4.
10
Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Bangkok, Thailand, and Their Detection by the Carba NP and Modified Carbapenem Inactivation Method Tests.来自泰国曼谷的产碳青霉烯酶的耐碳青霉烯类肠杆菌科细菌及其通过Carba NP和改良碳青霉烯灭活方法试验的检测。
Microb Drug Resist. 2018 Sep;24(7):1006-1011. doi: 10.1089/mdr.2018.0080. Epub 2018 May 21.
本文引用的文献
1
Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission.评估住院后连续筛查培养以检测产碳青霉烯酶肠杆菌科。
J Hosp Infect. 2018 Sep;100(1):15-20. doi: 10.1016/j.jhin.2018.05.024. Epub 2018 Jun 5.
2
An evaluation of a toolkit for the early detection, management, and control of carbapenemase-producing Enterobacteriaceae: a survey of acute hospital trusts in England.产碳青霉烯酶肠杆菌科的早期检测、管理和控制工具包的评估：对英格兰急性医院信托的调查。
J Hosp Infect. 2018 Aug;99(4):381-389. doi: 10.1016/j.jhin.2018.03.007. Epub 2018 Mar 9.
3
Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant into healthcare settings: guidance from the European Centre for Disease Prevention and Control.预防耐碳青霉烯类进入医疗机构的感染预防与控制措施及工具：欧洲疾病预防控制中心指南
Antimicrob Resist Infect Control. 2017 Nov 15;6:113. doi: 10.1186/s13756-017-0259-z. eCollection 2017.
4
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.ESCMID 指南：管理感染控制措施以减少住院患者中多重耐药革兰氏阴性菌传播。
Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55. doi: 10.1111/1469-0691.12427.
5
Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy.意大利新生儿重症监护病房中广泛耐药鲍曼不动杆菌的克隆传播和患者感染危险因素。
J Hosp Infect. 2012 Dec;82(4):260-5. doi: 10.1016/j.jhin.2012.08.018. Epub 2012 Oct 24.
6
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.应用全基因组测序追踪医院碳青霉烯类耐药肺炎克雷伯菌暴发疫情
Sci Transl Med. 2012 Aug 22;4(148):148ra116. doi: 10.1126/scitranslmed.3004129.
Zotero 插件